ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Research Grant Funding To Exceed $1.5 Billion, Support 4,800 Grants, In FY00.

January 14, 2000

CHOP Evaluation Plan In Jan. 22 Issue

January 15, 1982

Alan Rabson Named Acting NCI Director

October 5, 2001

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

Large Pregnancy Weight Gain Raises Risk For Breast Cancer

May 31, 2002

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013